Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING and NAPLES, Fla., May 22, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China'… For the full story, visit the source.
BusinessMaharashtra
Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING and NAPLES, Fla., May 22, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China'…
PRNewswire· 4 months ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire